Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Timing of Transcatheter Aortic Valve Implantation and Percutaneous Coronary Intervention - The TAVI PCI Trial

NCT04310046 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.

NCT NCT04310046
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04310046 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Timing of Transcatheter Aortic Valve Implantation and Percutaneous Coronary Intervention - The TAVI PCI Trial
Lead sponsor
University of Zurich
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 30, 2020
Completion date
July 31, 2031
Enrollment
986 (estimated)
Sites
48

Conditions

As the registry lists them; a condition with its own page is linked.

aortic stenosis, coronary artery disease, pci, tavi